Page last updated: 2024-11-01

nevirapine and Breast Cancer

nevirapine has been researched along with Breast Cancer in 1 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, R1
Lagakos, SW1
Gray, RJ1

Other Studies

1 other study available for nevirapine and Breast Cancer

ArticleYear
Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring.
    Biostatistics (Oxford, England), 2010, Volume: 11, Issue:4

    Topics: Algorithms; Biostatistics; Breast Neoplasms; Clinical Trials as Topic; Computer Simulation; Confiden

2010